News Nuformix plc

Equities

Market Closed - London S.E. Other stock markets 11:35:09 2024-04-26 am EDT			5-day change	1st Jan Change
0.19 ^GBX	-5.00%		-7.32%	-41.54%

Mar. 01	Nuformix announces subscription to raise GBP150,000	AN
Jan. 15	Nuformix plc Reports Earnings Results for the Eighteen Months Ended September 30, 2023	CI

Nuformix announces subscription to raise GBP150,000	Mar. 01	AN
Nuformix plc Reports Earnings Results for the Eighteen Months Ended September 30, 2023	Jan. 15	CI
Nuformix narrows annual loss as develops drug assets	Jan. 03	AN
Earnings Flash (NFX.L) NUFORMIX Reports FY23 Loss GBX-0.12	Jan. 03	MT
Nuformix plc Reports Earnings Results for the Half Year Ended September 30, 2023	Jan. 03	CI
Nuformix gets patent in Japan for pulmonary fibrosis treatment NXP002	23-10-23	AN
Nuformix Receives Japanese Patent for Pulmonary Fibrosis Treatment; Shares Surge	23-10-23	MT
Nuformix plc Announces Notice of Allowance of NXP002 Patent in Japan	23-10-23	CI
Nuformix to fund its unlicensed programs with NXP001 windfall	23-10-05	AQ
Nuformix Updates Oxilio Agreement for NXP001	23-09-18	MT
Nuformix to receive milestone payments from Oxilio pact	23-09-18	AN
Nuformix plc Receives New NXP001 Development Milestone Payments in Updated Oxilio Agreement	23-09-18	CI
Nuformix loss narrows; near-term goal to focus on NXP002 asset	23-05-22	AN
Earnings Flash (NFX.L) NUFORMIX Posts FY23 EPS GBX0.11	23-05-22	MT
Earnings Flash (NFX.L) NUFORMIX Posts Fiscal H1 EPS GBX0.11	23-05-22	MT
Nuformix plc Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-22	CI
Nuformix says NXP002 shows anti-inflammatory effect	23-05-18	AN
Nuformix to Launch Partnering Process for Inhaled Lung Disease Drug	23-05-18	MT
Nuformix plc Announces Update Regarding the NXP002 Programme	23-05-18	CI
FTSE 100 Inches Up as Market Awaits Key Inflation, Earnings Figures	23-04-17	DJ

No results for this search